Kruesi MJ - Search Results

1

Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial.

DeVane CL, Charles JM, Abramson RK, Williams JE, Carpenter LA, Raven S, Gwynette F, Stuck CA, Geesey ME, Bradley C, Donovan JL, Hall AG, Sherk ST, Powers NR, Spratt E, Kinsman A, Kruesi MJ, Bragg JE Jr. DeVane CL, et al. Among authors: kruesi mj. Pharmacotherapy. 2019 Jun;39(6):626-635. doi: 10.1002/phar.2271. Epub 2019 May 29. Pharmacotherapy. 2019. PMID: 31063671 Free PMC article. Clinical Trial.

2

Paraphilias: a double-blind crossover comparison of clomipramine versus desipramine.

Kruesi MJ, Fine S, Valladares L, Phillips RA Jr, Rapoport JL. Kruesi MJ, et al. Arch Sex Behav. 1992 Dec;21(6):587-93. doi: 10.1007/BF01542257. Arch Sex Behav. 1992. PMID: 1482282 Clinical Trial.

3

Corn Silk Tea and Enuresis.

Kruesi MJ. Kruesi MJ. J Child Adolesc Psychopharmacol. 2016 Aug;26(6):569-70. doi: 10.1089/cap.2012.0125. Epub 2014 Oct 20. J Child Adolesc Psychopharmacol. 2016. PMID: 25329720 No abstract available.

4

A pilot study of the effects of atomoxetine on driving performance in adults with ADHD.

Barkley RA, Anderson DL, Kruesi M. Barkley RA, et al. J Atten Disord. 2007 Feb;10(3):306-16. doi: 10.1177/1087054706292122. J Atten Disord. 2007. PMID: 17242426 Clinical Trial.

5

Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder.

Castellanos FX, Elia J, Kruesi MJ, Marsh WL, Gulotta CS, Potter WZ, Ritchie GF, Hamburger SD, Rapoport JL. Castellanos FX, et al. Among authors: kruesi mj. Neuropsychopharmacology. 1996 Feb;14(2):125-37. doi: 10.1016/0893-133X(95)00077-Q. Neuropsychopharmacology. 1996. PMID: 8822535 Clinical Trial.

6

Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents.

Kruesi MJ, Rapoport JL, Hamburger S, Hibbs E, Potter WZ, Lenane M, Brown GL. Kruesi MJ, et al. Arch Gen Psychiatry. 1990 May;47(5):419-26. doi: 10.1001/archpsyc.1990.01810170019003. Arch Gen Psychiatry. 1990. PMID: 1691910

7

CSF somatostatin in childhood psychiatric disorders: a preliminary investigation.

Kruesi MJ, Swedo S, Leonard H, Rubinow DR, Rapoport JL. Kruesi MJ, et al. Psychiatry Res. 1990 Sep;33(3):277-84. doi: 10.1016/0165-1781(90)90044-6. Psychiatry Res. 1990. PMID: 1700858

8

Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder.

Castellanos FX, Elia J, Kruesi MJ, Gulotta CS, Mefford IN, Potter WZ, Ritchie GF, Rapoport JL. Castellanos FX, et al. Among authors: kruesi mj. Psychiatry Res. 1994 Jun;52(3):305-16. doi: 10.1016/0165-1781(94)90076-0. Psychiatry Res. 1994. PMID: 7527565 Clinical Trial.

9

A 2-year prospective follow-up study of children and adolescents with disruptive behavior disorders. Prediction by cerebrospinal fluid 5-hydroxyindoleacetic acid, homovanillic acid, and autonomic measures?

Kruesi MJ, Hibbs ED, Zahn TP, Keysor CS, Hamburger SD, Bartko JJ, Rapoport JL. Kruesi MJ, et al. Arch Gen Psychiatry. 1992 Jun;49(6):429-35. doi: 10.1001/archpsyc.1992.01820060009001. Arch Gen Psychiatry. 1992. PMID: 1376104

10

Determinants of expressed emotion in families of disturbed and normal children.

Hibbs ED, Hamburger SD, Lenane M, Rapoport JL, Kruesi MJ, Keysor CS, Goldstein MJ. Hibbs ED, et al. Among authors: kruesi mj. J Child Psychol Psychiatry. 1991 Jul;32(5):757-70. doi: 10.1111/j.1469-7610.1991.tb01900.x. J Child Psychol Psychiatry. 1991. PMID: 1918226

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters